IK Investment Partners has agreed to sell a Dutch business that produces over-the-counter drugs and food supplements to an entity owned by Charterhouse Capital Partners.

Financial details of the sale of Vemedia were undisclosed in the statement on July 28, but a person familiar with the matter said that the enterprise value was approximately €375 million, with the sale netting IK a return of 2.4x, the person added.